
Merilyn Varghese, MD MSc
@merilynvarghese
Cardiologist @Yale | Fellowship @BIDMC | Former Chief Resident @YaleIM_Chiefs
ID: 1509238155194556416
30-03-2022 18:37:09
35 Tweet
174 Followers
219 Following

The number of Medicare beneficiaries participating in cardiac rehabilitation dropped at the onset of the pandemic and had yet to return to pre-pandemic levels as of December 2021 Dhruv Kazi BIDMC Merilyn Varghese, MD MSc #AHA22 #CardioTwitter healio.com/news/cardiolog…

Marked declines in #CardiacRehab use since the start of the pandemic. Merilyn Varghese, MD MSc discusses how this may exacerbate disparities in CV outcomes and offers potential solns. 10.15am tomorrow in S104B. Join us! BIDMC Smith Center

Tonight at 7:30pm on Yale Cancer Answers, join us to learn about the field of classical #hematology and current research initiatives into rare blood disorders with George Goshua, MD MSc. Listen live on Connecticut Public or iTunes. Yale Hematology Oncology Fellows YaleHematology Smilow Cancer Hospital Yale School of Medicine


We can save more lives for our alloimmunized patients medscape.com/viewarticle/98… @medscape 2nd #ASH22 Press Program abstract w/ brilliance from Yale Lab Medicine #RGHauser Chris Tormey #JEHendrickson (now Emory), Harvard Health Policy and Management Ankur Pandya and Satoko Ito, MD PhD (#GoshuaLab). Yale Cancer Center

📢💫Satoko Ito, MD PhD = hematologist+palliative care MD+epidemiologist! Her first Yale Cancer Center YaleHematology Yale School of Medicine pub Annals of Int Med in <6 weeks #GoshuaLab Editorial doi.org/10.7326/M22-34… Potent CEA by👏Shuchi Gulati MD: all oral-Xa inhibitors v LMWH in CAT doi.org/10.7326/M22-12…


🚨Annals of Int Med embargo lift on Yale School of Medicine - Harvard Health Policy and Management collaboration: Quantification of health equity weight thresholds w/ DCEA of gene therapy vs standard-of-care in sickle cell disease Dr Cece Calhoun Satoko Ito, MD PhD Lyndon James Andrea Luviano Lakshmanan Krishnamurti Ankur Pandya


Dr. George Goshua has been appointed to the Annals of Int Med Editorial Board for a 3-year term. Read more about George Goshua, MD MSc and the role. YaleHematology Yale Cancer Center Smilow Cancer Hospital medicine.yale.edu/intmed/news-ar…

Now published in American Journal of Cardiology "Real-World Experience and Outcomes With Percutaneous Coronary Intervention for Protected Versus Unprotected Left Main Coronary Artery Disease" Full article: authors.elsevier.com/c/1j5bVgQl0d~5 Led by Pedro Engel, MD, FACC, FSCAI, Veterans Affairs, and our team Yale Cardiology


JAMA Cardiology We profiled exercise BP using plasma proteomics in search of new HTN/CVD biomarkers. TGFBR3 emerged as a novel marker of exercise SBP & incident HTN across multiple cohorts & platforms, supported by genetic/MR experiments Huge team effort 🙏 bit.ly/4cg5krF


Thank you Yale Cancer Center -> our trainees = why we do this: 4 most recent (May & June 2024) first-author trainee 🌟s Yale School of Medicine Yale Internal Medicine Johns Hopkins Hematology & NIH Critical Care Medicine Christina Waldron Satoko Ito, MD PhD #cecilyallen #danielwang Ayesha Butt, MD Rhys Richmond Harlan Krumholz Hanny Al-Samkari, MD Adam Cuker MD, MS


Now in press in MyJSCAI, our comprehensive review "Evaluating Ischemic Heart Disease in Women: Focus on Angina With Nonobstructive Coronary Arteries (ANOCA)" jscai.org/article/S2772-… How should we evaluate women with ischemic heart disease? This our approach Cesia Gallegos, MD MHS FASNC
